Search - tctmd.com

Displaying 381 - 400 of 707

Sort: Relevancy | Date

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

Statins Not Linked to Dementia or Memory Changes: ASPREE

Michael O'Riordan

June 21, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

Todd Neale

June 10, 2021

News Conference News EAS 2021

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

Michael O'Riordan

June 07, 2021

News Daily News

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

L.A. McKeown

June 04, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Conference News ACC 2021

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

L.A. McKeown

May 24, 2021

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Todd Neale

May 17, 2021

News Conference News ACC 2021

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

L.A. McKeown

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

Advertisement

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Making the Case for Sex-Specific CVD Guidelines

OMT Boosts Survival in Revascularized Patients at 10 Years

Statins Not Linked to Dementia or Memory Changes: ASPREE

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself

Central and Eastern Europe Failing to Achieve LDL Treatment Targets: DA VINCI

It Pays to Reward Doctors for Risk-Stratifying Patients, Early Data Hint

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

June 2021 News Roundup

Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics

Elective Revascularization, Better Long-term Survival: Meta-analysis

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19

Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content